Real-time enrollment status for this tumor-associated hyperinsulinism clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06881992 |
| Recruiting Status | Recruiting |
| Condition | Tumor-Associated Hyperinsulinism |
| Phase | Clinical Trial |
| Target Enrollment | 48 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Rezolute |
| Last Updated on CT.gov | December 30, 2025 (Dec 30, 2025) |
As of March 2, 2026: Clinical trial NCT06881992 is currently recruiting participants. This clinical trial study for tumor-associated hyperinsulinism is actively seeking new participants at 4 locations across the United States. The study is sponsored by Rezolute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06881992 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06881992 was last updated Dec 30, 2025 (December 30, 2025). HelloStudys verifies this status automatically.